ShareValue scores for 300463.SHE: Valuation 68, Quality 43, Growth 30, Health 36.

300463.SHE
SZSE

Maccura Biotechnology Co Ltd

CN¥9.35(+3.20%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

3% to 17%
Valuation
68
Fair Value
Price vs Value
Quality
43
Moderate
Business Strength
Growth
30
Weak
Revenue & Earnings
Health
36
Stressed
Financial Stability
Momentum
32
Bearish
Price Trend

Company Details

About

Maccura Biotechnology Co.Ltd engages in the research, development, manufacture, and sale of in vitro diagnostic products; and provides related services for medical laboratories in China and internationally. The company offers laboratory automation solutions, such as hematology analysis workstations; immunoassay products, such as chemiluminescence analyzers and reagents; molecular products, such as digital PCR and extraction systems, and PCR kits; urinalysis analyzer systems and semi-automatic urine analyzers; and hemostasis solutions, including coagulation and semi-automatic coagulation analyzers. It also provides clinical chemistry products, such as glycohemoglobin and protein analyzer, biochemistry systems, and chemistry regents; blood group product solutions; and pathology solutions, such as a liquid-based cytology processing system technologies. In addition, the company offers Mike Smart Lab, a patient-centered medical laboratory system solution based on automation and digital intelligence. Maccura Biotechnology Co.Ltd was founded in 1994 and is headquartered in Chengdu, China. Address: No.1006, Qihuang Road, Chengdu, China, 610219

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026